Shaperon, Inc.

[On Demand]
Shaperon is a clinical-stage biotech company with novel inflammasome inhibitors that regulate both priming and activation phase, suppressing a broad spectrum of pro-inflammatory cytokines including IL-1b, TNF-a, IL-6, etc.
Currently two phase 2 studies are on-going in atopic dermatitis and COVID-19 pneumonia.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Korea - South Korea
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
NuGel (Atopic dermatitis), NuSepin (COVID-19 pneumonia)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Vice president
Shaperon Inc.